How similar is similar enough? A sufficient similarity case study with Ginkgo biloba extract

Food and Chemical Toxicology

Volumn 118, Issue , 2018, Pages 328-339

  Catlin, Natasha R ^a   Collins, Bradley J ^a   Auerbach, Scott S ^a   Ferguson, Stephen S ^a   Harnly, James M ^b   Gennings, Chris ^c   Waidyanatha, Suramya ^a   Rice, Glenn E ^d   Smith Roe, Stephanie L ^a   Witt, Kristine L ^a   Rider, Cynthia V ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILOBALIDE; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE C; GINKGOLIDE J; ISORHAMNETIN; KAEMPFEROL; QUERCETIN; RUTOSIDE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; GENE EXPRESSION; HEP-G2 CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER WEIGHT; MALE; NONHUMAN; PHARMACEUTICAL EQUIVALENCE; QUANTITATIVE ANALYSIS; RAT; RISK ASSESSMENT; ANIMAL; BIOASSAY; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GINKGO BILOBA; LIVER CELL; PHYTOTHERAPY; THERAPEUTIC EQUIVALENCE;

ANIMALS; BIOLOGICAL ASSAY; GENE EXPRESSION REGULATION; GINKGO BILOBA; HEPATOCYTES; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; THERAPEUTIC EQUIVALENCY;

EID: 85047075145     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2018.05.013     Document Type: Article

References (40)

1. AOAC International Guidelines for Validation of Botanical Identification Methods, J. AOAC Int. 95 (2012), 268–272.
2. Braquet, P., The ginkgolides: potent platelet-activating factor antagonists isolated from ginkgo biloba L.: chemistry, pharmacology and clinical application. Drugs Future 12 (1987), 643–699.
3. Cherian, M.T., Chai, S.C., Chen, T.S., Small-molecule modulators of the constitutive androstane receptor. Expet Opin. Drug Metabol. Toxicol. 11 (2015), 1099–1114.
4. Clarke, T., Black, L., Stussman, B., Barnes, P., Nahin, R., Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002-2012. 2015, National Health Statistics Reports. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
5. Cohen, P.A., The supplement paradox: negligible benefits, robust consumption. JAMA 316 (2016), 1453–1454.
6. Defeudis, F.V., A brief history of EGb 761 and its therapeutic uses. Pharmacopsychiatry 36:Suppl. 1 (2003), S2–S7.
7. Ding, X.P., Qi, J., Chang, Y.X., Mu, L.L., Zhu, D.N., Yu, B.Y., Quality control of flavonoids in Ginkgo biloba leaves by high-performance liquid chromatography with diode array detection and on-line radical scavenging activity detection. J. Chromatogr. A 1216 (2009), 2204–2210.
8. Edwards, L., Wanless, I.R., Mechanisms of liver involvement in systemic disease. Best Pract. Res. Clin. Gastroenterol. 27 (2013), 471–483.
9. Fransen, H.P., Pelgrom, S.M.G.J., Stewart-Knox, B., De Kaste, D., Verhagen, H., Assessment of health claims, content, and safety of herbal supplements containing Ginkgo biloba. Food Nutr. Res., 54, 2010.
10. Gafner, S., Blumenthal, M., Foster, S., Cardellina, J., Khan, I.A., Upton, R., The ABC-AHP-NCNPR botanical adulterants program's laboratory guidance on analytical methods to detect adulterants in botanical materials. Planta Med., 81, 2015 888–888.
11. Grimm, F.A., Iwata, Y., Sirenko, O., Chappell, G.A., Wright, F.A., Reif, D.M., Braisted, J., Gerhold, D.L., Yeakley, J.M., Shepard, P., Seligmann, B., Roy, T., Boogaard, P.J., Ketelslegers, H.B., Rohde, A.M., Rusyn, I., A chemical-biological similarity-based grouping of complex substances as a prototype approach for evaluating chemical alternatives. Green Chem. 18 (2016), 4407–4419.
12. Guo, L., Mei, N., Liao, W., Chan, P.C., Fu, P.P., Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered network. OMICS 14 (2010), 75–90.
13. Harnly, J., Chen, P., Harrington, P.D., Probability of identification: adulteration of American Ginseng with Asian Ginseng. J. AOAC Int. 96 (2013), 1258–1265.
14. Harnly, J., Chen, P., Sun, J.H., Huang, H.L., Colson, K.L., Yuk, J., Mccoy, J.A.H., Reynaud, D.T.H., Harrington, P.B., Fletcher, E.J., Comparison of flow injection MS, NMR, and DNA sequencing: methods for identification and authentication of black cohosh (Actaea racemosa). Planta Med. 82 (2016), 250–262.
15. Harnly, J.M., Luthria, D., Chen, P., Detection of adulterated ginkgo biloba supplements using chromatographic and spectral fingerprints. J. AOAC Int. 95 (2012), 1579–1587.
16. Heads, J.A., Hawthorne, R.L., Lynagh, T., Lynch, J.W., Structure-activity analysis of ginkgolide binding in the glycine receptor pore. J. Neurochem. 105 (2008), 1418–1427.
17. Hewitt, N.J., Lecluyse, E.L., Ferguson, S.S., Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations. Xenobiotica 37 (2007), 1196–1224.
18. Huang, S.H., Duke, R.K., Chebib, M., Sasaki, K., Wada, K., Johnston, G.A.R., Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha(1)beta(2)gamma(2L) GABA(A) receptors. Eur. J. Pharmacol. 494 (2004), 131–138.
19. Kressmann, S., Muller, W.E., Blume, H.H., Pharmaceutical quality of different Ginkgo biloba brands. J. Pharm. Pharmacol. 54 (2002), 661–669.
20. Lau, A.J., Yang, G.X., Rajaraman, G., Baucom, C.C., Chang, T.K.H., Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor. Drug Metabol. Dispos. 40 (2012), 178–186.
21. Lin, L.Z., Chen, P., Ozcan, M., Harnly, J.M., Chromatographic profiles and identification of new phenolic components of Ginkgo biloba leaves and selected products. J. Agric. Food Chem. 56 (2008), 6671–6679.
22. Maeda, J., Inoue, K., Ichimura, R., Takahashi, M., Kodama, Y., Saito, N., Yoshida, M., Essential role of constitutive androstane receptor in Ginkgo biloba extract induced liver hypertrophy and hepatocarcinogenesis. Food Chem. Toxicol. 83 (2015), 201–209.
23. Maeda, J., Kijima, A., Inoue, K., Ishii, Y., Ichimura, R., Takasu, S., Kuroda, K., Matsushita, K., Kodama, Y., Saito, N., Umemura, T., Yoshida, M., In vivo genotoxicity of ginkgo biloba extract in gpt delta mice and constitutive androstane receptor knockout mice. Toxicol. Sci. 140 (2014), 298–306.
24. Marshall, S., Gennings, C., Teuschler, L.K., Stork, L.G., Tornero-Velez, R., Crofton, K.M., Rice, G.E., An empirical approach to sufficient similarity: combining exposure data and mixtures toxicology data. Risk Anal. 33 (2013), 1582–1595.
25. Martin, M.T., Dix, D.J., Judson, R.S., Kavlock, R.J., Reif, D.M., Richard, A.M., Rotroff, D.M., Romanov, S., Medvedev, A., Poltoratskaya, N., Gambarian, M., Moeser, M., Makarov, S.S., Houck, K.A., Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA's ToxCast program. Chem. Res. Toxicol. 23 (2010), 578–590.
26. Mercado-Feliciano, M., Cora, M.C., Witt, K.L., Granville, C.A., Hejtmancik, M.R., Fomby, L., Knostman, K.A., Ryan, M.J., Newbold, R., Smith, C., Foster, P.M., Vallant, M.K., Stout, M.D., An ethanolic extract of black cohosh causes hematological changes but not estrogenic effects in female rodents. Toxicol. Appl. Pharmacol. 263 (2012), 138–147.
27. Murray, F., Roth, R., Nicolich, M., Gray, T., Simpson, B., The relationship between developmental toxicity and aromatic-ring class profile of high-boiling petroleum substances. Regul. Toxicol. Pharmacol. 67 (2013), S46–S59.
28. NTP, NTP technical report on the toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (gavage studies). NTP, (eds.) Technical Report Series. Research Triangle Park, NC: NIEHS/NTP, 2013.
29. Pferschy-Wenzig, E.M., Bauer, R., The relevance of pharmacognosy in pharmacological research on herbal medicinal products. Epilepsy Behav. 52 (2015), 344–362.
30. Rice, G.E., Teuschler, L.K., Bull, R.J., Simmons, J.E., Feder, P.I., Evaluating the similarity of complex drinking-water disinfection by-product mixtures: overview of the issues. J. Toxicol. Environ. Health 72 (2009), 429–436.
31. Rider, C.V., Nyska, A., Cora, M.C., Kissling, G.E., Smith, C., Travlos, G.S., Hejtmancik, M.R., Fomby, L.M., Colleton, C.A., Ryan, M.J., Kooistra, L., Morrison, J.P., Chan, P.C., Toxicity and carcinogenicity studies of Ginkgo biloba extract in rat and mouse: liver, thyroid, and nose are targets. Toxicol. Pathol. 42 (2014), 830–843.
32. Romanov, S., Medvedev, A., Gambarian, M., Poltoratskaya, N., Moeser, M., Medvedeva, L., Gambarian, M., Diatchenko, L., Makarov, S., Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors. Br. J. Pharmacol. 5 (2008), 253–260.
33. Schenck, K.M., Sivaganesan, M., Rice, G.E., Correlations of water quality parameters with mutagenicity of chlorinated drinking water samples. J. Toxicol. Environ. Health 72 (2009), 461–467.
34. Shimizu, Y., Liver in systemic disease. World J. Gastroenterol. 14 (2008), 4111–4119.
35. Shipkowski, K.A., Betz, J.M., Birnbaum, L.S., Bucher, J.R., Coates, P.M., Hopp, D.C., Mackay, D., Oketch-Rabah, H., Walker, N.J., Welch, C., Rider, C.V., Naturally complex: perspectives and challenges associated with botanical dietary supplement safety assessment. Food Chem. Toxicol., 2018, 10.1016/j.fct.2018.04.007 (Epub ahead of print).
36. Sloley, B.D., Tawfik, S.R., Scherban, K.A., Tam, Y.K., Quality control analyses for ginkgo extracts require analysis of intact flavonol glycosides. J. Food Drug Anal. 11 (2003), 102–107.
37. Smith-Roe, S.L., Swartz, C.D., Shepard, K.G., Bryce, S.M., Dertinger, S.D., Waidyanatha, S., Kissling, G.E., Auerbach, S.S., Witt, K.L., Black cohosh extracts and powders induce micronuclei, a biomarker of genetic damage, in human cells. Environ. Mol. Mutagen., 2018, 10.1002/em.22182.
38. Swift, B., Pfeifer, N.D., Brouwer, K.L.R., Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metabol. Rev. 42 (2010), 446–471.
39. The United States Pharmacopeial Convention, Dietary Supplements Compendium. 2015, The United States Pharmacopeial Convention, Rockville, MD.
40. van Beek, T.A., Montoro, P., Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J. Chromatogr. A 1216 (2009), 2002–2032.